Ilimis, “overcomes” the limitations of ‘Aβ treatment’…what is the ‘TAM’ approach?

BMS Korea selects the winner of the "Seoul-BMS Innovation Square Challenge"

Seoul Biohub Successfully Holds Swiss Networking Day

[Science and Technology Award of the Month] Professor Kim Chan-hyuk of KAIST Develops a New Alzheimer's Treatment Using the Immune System

"Challenge of a new Alzheimer's treatment with GAIA platform"

Lead to be generated within this year for Alzheimer’s Disease treatment without inflammation

Illimis Therapeutics focusing on Neuroimmune Disorders

Illimis, 20 billion won Series A, Neuroinflammation↓ GAIA Platform

Illimis Therapeutics completes 20 billion won Series A

Illimis Therapeutics finalizing 20 billion won Series A

Venture Capitalist's promising start-up of this year

From heavy equipment platforms to waste batteries, which are the 41 new Baby Unicorn companies?

Removal of toxic proteins without inflammatory response

Development of treatment for Alzheimer's, a degenerative brain disease that causes dementia / YTN Science

Development of a new Alzheimer's treatment without serious side effects

Development of a new Alzheimer's treatment without serious side effects

Development of a novel Alzheimer's Disease therapeutic candidate without inflammatory side effects

Will there be a way to treat Alzheimer's without side effects?

Ilimis, ‘New AD Strategy’ GAIA Platform “Nature Medicine Thesis”

Novel Alzheimer’s Therapy without Inflammatory Side Effects